Evidence map›Paper›PMID 26451472›Full record

ArticleChemical research in toxicology2015

Thioredoxin Cross-Linking by Nitrogen Mustard in Lung Epithelial Cells: Formation of Multimeric Thioredoxin/Thioredoxin Reductase Complexes and Inhibition of Disulfide Reduction.

Yi-Hua Jan, Diane E Heck, Robert P Casillas, Debra L Laskin, Jeffrey D Laskin

Abstract read
In one paragraph

Article in Chemical research in toxicology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Mustard vesicant-induced lung injury: Advances in therapy.Toxicology and applied pharmacology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Yi-Hua JanDepartment of Environmental and Occupational Medicine, Rutgers University-Robert Wood Johnson Medical School , Piscataway, New Jersey 08854, United States.
Diane E HeckDepartment of Environmental Health Science, New York Medical College , Valhalla, New York 10595, United States.
Robert P CasillasMRIGlobal , Kansas City, Missouri 64110, United States.
Debra L LaskinDepartment of Pharmacology and Toxicology, Rutgers University , Piscataway, New Jersey 08854, United States.
Jeffrey D LaskinDepartment of Environmental and Occupational Medicine, Rutgers University-Robert Wood Johnson Medical School , Piscataway, New Jersey 08854, United States.
Environmental and Occupational Health Sciences Institute · USMRIGlobal · USNew York Medical College · USRutgers, The State University of New Jersey · US

Funding

UMDNJ/Rutgers University CounterACT Research Center of ExcellenceU54AR055073 · NIAMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI HECK, DIANE E · 2006 to 2024
$71.4M
Translational Research Support CoreP30ES005022 · NIEHS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI ROBERT John LAUMBACH · 1988 to 2026
$47.4M
ACTIVATED MACROPHAGES AND OZONE TOXICITYR01ES004738 · NIEHS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI Debra L Laskin · 1989 to 2026
$9.0M
Developing Drugs to Mitigate Parathion IntoxicationU01NS079249 · NINDS · RBHS-SCHOOL OF PUBLIC HEALTH · PI LASKIN, JEFFREY D, RICHARDSON, JASON R · 2013 to 2017
$4.0M
Gene-Environment Interactions in Neurodegeneration: Role of Efflux TransportersR01ES021800 · NIEHS · RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL · PI ALEKSUNES, LAUREN M, RICHARDSON, JASON R · 2014 to 2018
$1.9M
Macrophages and Inflammatory Mediators in Silica-Induced CarcinogenesisR01CA132624 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI LASKIN, DEBRA L · 2008 to 2012
$1.5M
NCI NIH HHS CA132624NCI NIH HHS R01 CA132624NIAMS NIH HHS AR055073NIAMS NIH HHS U54 AR055073NIEHS NIH HHS ES004738NIEHS NIH HHS ES005022NIEHS NIH HHS ES021800NIEHS NIH HHS P30 ES005022NIEHS NIH HHS R01 ES004738NIEHS NIH HHS R01 ES021800NINDS NIH HHS NS079249NINDS NIH HHS U01 NS079249
6 · The paper itself

Abstract

The thioredoxin (Trx) system, which consists of Trx and thioredoxin reductase (TrxR), is a major cellular disulfide reduction system important in antioxidant defense. TrxR is a target of mechlorethamine (methylbis(2-chloroethyl)amine; HN2), a bifunctional alkylating agent that covalently binds to selenocysteine/cysteine residues in the redox centers of the enzyme, leading to inactivation and toxicity. Mammalian Trx contains two catalytic cysteines; herein, we determined if HN2 also targets Trx. HN2 caused a time- and concentration-dependent inhibition of purified Trx and Trx in A549 lung epithelial cells. Three Trx cross-linked protein complexes were identified in both cytosolic and nuclear fractions of HN2-treated cells. LC-MS/MS of these complexes identified both Trx and TrxR, indicating that HN2 cross-linked TrxR and Trx. This is supported by our findings of a significant decrease of Trx/TrxR complexes in cytosolic TrxR knockdown cells after HN2 treatment. Using purified recombinant enzymes, the formation of protein cross-links and enzyme inhibition were found to be redox status-dependent; reduced Trx was more sensitive to HN2 inactivation than the oxidized enzyme, and Trx/TrxR cross-links were only observed using reduced enzyme. These data suggest that HN2 directly targets catalytic cysteine residues in Trx resulting in enzyme inactivation and protein complex formation. LC-MS/MS confirmed that HN2 directly alkylated cysteine residues on Trx, including Cys32 and Cys35 in the redox center of the enzyme. Inhibition of the Trx system by HN2 can disrupt cellular thiol-disulfide balance, contributing to vesicant-induced lung toxicity.

Indexed as

Cell Line, TumorCross-Linking ReagentsDisulfidesEpithelial CellsHumansInsulinLungMechlorethamineModels, MolecularOxidation-ReductionThioredoxin-Disulfide ReductaseThioredoxinsCross-Linking ReagentsDisulfidesInsulinMechlorethamineThioredoxin-Disulfide ReductaseThioredoxinsTXN protein, human

Identifiers

PMID26451472
PMCPMC4877171
OpenAlexW2292231288

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.